Show
Sort by
-
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs
-
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
-
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
-
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
-
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation
-
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
-
Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
-
The miR-17-92 gene cluster is amplified and overexpressed in retinoblastoma
-
ALK Mutation Analysis in Patients of the German Neuroblastoma Study
-
Prognostic role and functional analyses of miRNA expression in neuroblastoma
-
Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome